The redox-sensitive transcription factor NF-E2 -related factor 2 (Nrf2) plays a key role in preserving a healthy endothelial phenotype and maintaining the functional integrity of the vasculature. Previous studies demonstrated that aging is associated with Nrf2 dysfunction in endothelial cells, which alters redox signaling and likely promotes the development of large vessel disease. Much less is known about the consequences of Nrf2 dysfunction at the level of the microcirculation. To test the hypothesis that Nrf2 regulates angiogenic capacity of endothelial cells, we determined whether disruption of Nrf2 signaling (by siRNA knockdown of Nrf2 and overexpression of Keap1, the cytosolic repressor of Nrf2) impairs angiogenic processes in cultured human coronary arterial endothelial cells stimulated with vascular endothelial growth factor and insulin-like growth factor-1. In the absence of functional Nrf2, coronary arterial endothelial cells exhibited impaired proliferation and adhesion to vitronectin and collagen. Disruption of Nrf2 signaling also reduced cellular migration (measured by a wound-healing assay using electric cell-substrate impedance sensing technology) and impaired the ability of coronary arterial endothelial cells to form capillary-like structures. Collectively, we fi nd that Nrf2 is essential for normal endothelial angiogenic processes, suggesting that Nrf2 dysfunction may be a potential mechanism underlying impaired angiogenesis and microvascular rarefaction in aging.
1
T HERE is increasing evidence to suggest that the " cap'n'collar " transcription factor NF-E2 -related factor 2 (Nrf2) has a key role in preserving a healthy endothelial phenotype and maintaining the functional integrity of the vasculature ( 1 -8 ) . Recent studies by our laboratories ( 9 , 10 ) and others ( 11 ) demonstrate that aging in blood vessels of laboratory rodents and nonhuman primates is associated with severe impairment of Nrf2 activity and dysregulation of cellular redox signaling. There is growing evidence suggesting that Nrf2 dysfunction contributes to the functional impairment of conduit arteries, increasing susceptibility of blood vessels to injury in metabolic diseases ( 5 ) and exacerbating the progress of atherosclerosis in aged animals ( 9 , 11 ) .
It is well known that aging signifi cantly impairs angiogenic capacity of microvascular endothelial cells ( 12 -21 ) , diminishing their responsiveness to angiogenic stimulation. It is thought that the age-related decline in the ability to form new blood vessels in the myocardium impairs both cardiac repair processes and adaptation to changes in myocardial oxygen supply and demand in the elderly (eg , in response to exercise or regional ischemia resulting from atherosclerotic narrowing of coronary arteries). However, the link between Nrf2 dysfunction and impaired angiogenic capacity of endothelial cells has not been elucidated.
The present study was designed to test the hypothesis that disruption of Nrf2 signaling impairs angiogenic capacity of coronary arterial endothelial cells (CAECs) , mimicking the vascular aging phenotype. To test our hypotheses, we determined whether disruption of Nrf2 signaling (by small interfering RNA [siRNA] knockdown and overexpression of Keap1, the cytosolic repressor of Nrf2) impairs angiogenic processes in cultured human CAEC s, including proliferation, adhesion, migration , and ability to form capillary-like structures.
M aterials and M ethods
Cell C ulture, Nrf2 K nockdown , and Keap1 
O verexpression
Primary human CAEC s (purchased from Cell Applications, Inc., San Diego, CA) were cultured in MesoEndo Endothelial Disruption of Nrf2 Signaling Impairs Angiogenic Capacity of Endothelial Cells: Implications for Microvascular Aging
Cell Growth Medium (Cell Applications, Inc . ) as described ( 4 , 5 , 22 ) . To disrupt Nrf2 signaling, Nrf2 was downregulated by RNA interference using proprietary siRNA sequences (Origen) and the electroporation-based Amaxa Nucleofector technology (Amaxa, Gaithersburg, MD), as we have previously reported ( 4 , 5 , 23 , 24 ) . Experiments were performed on day 2 after the transfection when gene silencing was optimal. Keap1 overexpression was achieved in CAECs by transfection with a Keap1 full-length complementary DNA (cDNA) encoding plasmid (Origen) as described ( 5 , 25 ) . To induce angiogenic processes , CAECs were treated with recombinant human vascular endothelial growth factor (VEGF, 100 ng/mL; R&D systems, Minneapolis, MN) and insulin-like growth factor-1 (IGF-1, 500 ng/m L ). All reagents used in this study were purchased from Sigma-Aldrich (St Louis, MO) unless otherwise indicated.
Cell A dhesion A ssays
Angiogenesis is a multistep process involving cell adhesion, proliferation, migration, and morphogenesis ( 26 ) . To determine the effects of Nrf2 signaling in regulation of the adhesion capacity of CAECs, cells were transfected with control plasmid, Nrf2 siRNA , or Keap1 cDNA. After 24 hours, they were collected, washed, counted , and labeled with the fl uorescent CyQuant dye (Invitrogen, Carlsbad, CA; incubation time: 60 minutes at 37 ° C). Equal amounts of cells, stimulated with VEGF (100 ng/m L ) or IGF-1 (500 ng/m L ), were seeded in 96-well plates previously coated with 50 μ L of vitronectin (1.6 μ g/m L ), collagen (50 μ g/m L ), fi bronectin (50 μ g/m L ), laminin (50 μ g/m L ), extracellular matrix compound (50 μ g/m L ; Cell Applications, Inc.) , or bovine serum albumin (BSA) (12 μ g/m L ), which was used as the negative control. After 3 hours incubation at 37 ° C, unattached cells were removed by rinsing the wells three times with warm phosphate-buffered saline . The ratio of adhering cells was quantifi ed by assessing the background-corrected fl uorescence (excitation /emission: 508/527 nm, respectively) using an Infi nite M200 plate reader (Tecan, Research Triangle Park, NC).
As an additional measurement, we used electric cellsubstrate impedance sensing (ECIS) technology (Applied Biophysics, Troy, NY) to monitor adhesion of CAECs to collagen. Briefl y, VEGF (100 ng/m L )-stimulated cells were seeded in collagen -coated 8-well array culture dishes containing gold fi lm surface electrodes (ECIS 8W1E; in each well , one active electrode [d: 250 μ m] and a large counter electrode). The same numbers of cells were added to each well in complete cell culture medium (2.5 × 10 5 cells per well). The arrays were placed in an incubator , and the time course for changes of capacitance (at 60 kHz) due to the adhesion of cells to the active electrode was obtained. Time to reach 50% cell adhesion ( t 50 Adhesion ) was used as an index of adhesiveness (100% change corresponds to the maximum level of cell coverage reached on the active electrode).
Cell P roliferation A ssay
Cell proliferation capacity was assessed in CAEC transfected with either Nrf2 siRNA or scrambled control plasmid using the fl ow cytometry -based Guava CellGrowth assay (Guava Technologies, Inc., Hayward, CA). Briefl y, cells were collected, resuspended in phosphate-buffered saline containing 0.1% BSA , and stained with 16 μ mol/L carboxyfl uorescein diacetate succinimidyl ester for 15 minutes at 37 ° C. This dye diffuses into cells and is cleaved by intracellular esterases to form an amine-reactive product that produces a detectable fl uorescence and binds covalently to intracellular lysine residues and other amine sources. Upon cell division , carboxyfl uorescein diacetate succinimidyl ester divides equally into the daughter cells halving the carboxyfl uorescein diacetate succinimidyl ester concentration of the mother cell; therefore, there is an inverse correlation between the fl uorescence intensity and the proliferation capacity of the cells. After incubation , unbound dye was quenched with serum-containing medium. Then, cells were washed three times and incubated for 24 hours with VEGF or IGF-1. Then, cells were collected, washed, stained with propidium iodide (to gate out dead cells) , and analyzed with a fl ow cytometer (Guava EasyCyte 8HT; Millipore, Billerica, MA).
Assessment of C ell M igration by ECIS-B ased W ound-H ealing A ssay
The ECIS technology was used to monitor migration of CAECs transfected with siRNA targeting Nrf2 (siNrf2) or a scrambled control vector in a wound-healing assay. Briefl y, CAECs (2.5 × 10 5 cells per well) were seeded in 8-well array culture dishes (ECIS 8W1E), placed in an incubator (37 ° C), and changes in resistance and impedance were continuously monitored. When impedance reached a plateau , the medium was changed to a serum-free medium. After 1 hour stabilization, cells in each well were subjected to an elevated fi eld pulse (wounding) of 5 mA applied for 20 seconds at 60 kHz, which killed the cells present on the small active electrode due to severe electroporation. The detachment of the dead cells was immediately evident as a sudden drop in resistance (monitored at 4000 Hz). VEGF (100 ng/m L ) was immediately added to each well. CAECs surrounding the active electrode that had not been subjected to the wounding then migrated inward to replace the detached dead cells resulting in resistance recovery (continuously monitored at 4000 Hz for up to 24 hours). Time to reach 50% resistance recovery (corresponding to 50% confl uence on the active electrode) was determined for control and siNrf2 -treated cells , and this parameter and the known physical dimensions of the electrode were used to calculate the migration rate (expressed as microns per h our ).
Tube F ormation A ssay
To investigate the infl uence of Nrf2 knockdown on tube formation ability, 24 hours after transfection with control plasmid, Nrf2 siRNA , or Keap1 cDNA, CAECs were plated on Geltrex Reduced Growth Factor Basement Membrane Matrix (Invitrogen) in Medium 200PRF (Invitrogen). Briefl y, 150 μ L per well of Geltrex was distributed in ice-cold 24-well plates. The gel was allowed to solidify while incubating the plates for 30 minutes at 37 ° C. CAECs were then seeded at a density of 5 × 10 4 cells per well and placed in the incubator for 24 hours. Microscopic images were captured using a Nikon Eclipse Ti microscope equipped with a × 10 phase contrast objective (Nikon Instruments , Inc., Melville, NY). The extent of tube formation was quantifi ed by measuring total tube length in fi ve random fi elds per well using NISElements microscope imaging software (Nikon Instruments , Inc . ). The mean of the total tube length per total area imaged ( micron tube per square millimeter ) was calculated for each well. Experiments were run in quadruplicates. The experimenter was blinded to the groups throughout the period of analysis.
Caspase-3/7 A ctivity A ssay
To determine changes in cellular viability and sensitivity to oxidative stressors, caspase-3/7 activity (a useful measure of apoptotic cell death) was assessed in CAECs with or without Nrf2 knockdown using the Caspase-Glo 3/7 assay kit (Promega, Madison, WI) as previously reported ( 27 -30 ) . CAECs were transfected with control scrambled plasmid, Nrf2 siRNA , or Keap1 cDNA, seeded in white-walled 96-well plates , and treated (for 18 h ours ) with the proapoptotic stimuli hydrogen peroxide (H 2 O 2 , 3 and 10 μ mol/L), oxidized low-density lipoprotein (5 μ g/m L ) , or high glucose (30 mmol/L) as previously described ( 31 , 32 ) . Then, CaspaseGlo 3/7 reagent was added to each well and mixed for 30 seconds , and peak luminescence signal intensities were determined using an Infi nite M200 plate reader (Tecan).
Data A nalysis
Statistical analyses were performed using one-way analysis of variance . p < .05 was considered statistically signifi cant. Data are expressed as means ± SEM s .
R esults

Disruption of Nrf2 S ignaling I nhibits A dhesion of CAECs to E xtracellular M atrix P roteins
To determine the role of Nrf2 on angiogenic capacity, we knocked down Nrf2 using siRNA or overexpressed Keap1, the cytosolic repressor of Nrf2 in CAECs. Cell adhesion experiments were performed to investigate whether disruption of Nrf2 signaling affects VEGF-and IGF-1 -induced adhesion of CAECs to different components of the extracellular matrix. We found that disruption of Nrf2 signaling by both Nrf2 siRNA treatment and overexpression of Keap1 impaired the ability of CAECs to adhere to vitronectin ( Figure 1A and B ) and collagen ( Figure 1C and D ) . The ability of cells to adhere to laminin was signifi cantly reduced ( Figure 1E and F ) , but only the effect of Nrf2 siRNA treatment to inhibit adhesion of IGF-1 -treated CAECs to laminin reached statistical signifi cance ( Figure 1F ). The magnitude of the effects of knockdown of Nrf2 and overexpression of Keap1 appears to differ in some of the assays ; however, the cause for this difference remains unknown.
In other experiments , we used ECIS technology to monitor changes of capacitance (at 60 kHz) due to the adhesion of VEGF (100 ng/m L )-stimulated cells to the collagen -coated active electrode ( Figure 2A ). Time to reach 50% cell adhesion ( t 50 Adhesion ) was used as an index of adhesiveness. We found that siRNA knockdown of Nrf2 resulted in a significant increase in t 50 Adhesion ( Figure 2B ) , indicating that downregulation of Nrf2 impairs the ability of VEGFtreated CAECs to adhere to collagen.
Disruption of Nrf2 S ignaling I mpairs P roliferative C apacity of CAECs
Proliferation represents a key step in angiogenesis. Proliferative capacity of CAECs transfected with siNrf2 or a scrambled control vector was compared after incubation with VEGF or IGF-1 for 24 hours. We found that Nrf2 knockdown signifi cantly increased carboxyfl uorescein diacetate succinimidyl ester fl uorescence in CAECs, indicating that proliferation capacity is signifi cantly impaired by Nrf2 dysfunction ( Figure 3 ) .
Disruption of Nrf2 S ignaling I mpairs the M igratory C apability of CAECs
The migratory capability of vascular endothelial cells has a pivotal role in the maintenance of microvascular integrity and angiogenesis. An ECIS-based wound-healing assay was used to assess the effect of disruption of Nrf2 signaling on migratory capability of VEGF-treated CAECs. We found that siRNA knockdown of Nrf2 signifi cantly increased the . Resistance (at 4000 Hz) was monitored every 160 seconds. Data are mean ± SEM ( n = 6 in each group). Time to reach 50% resistance recovery (corresponding to 50% confl uence on the active electrode) was determined for control and siNrf2 -treated cells ( t 1 and t 2 , respectively) , and this parameter and the known physical dimensions of the electrode were used to calculate the migration rate (expressed as microns per hour ). ( B ) Depicts the summary data for migration rate in control and siNrf2 -treated CAECs. Data are means ± SEM s ( n = 6 in each group), * p < .05 vs control.
time for the cells to reach 50% of the maximum confl uence ( Figure 4A ). Figure 4B indicates that the decline in the calculated migration rate in CAECs with Nrf2 knockdown was highly signifi cant ( Figure 4B ).
Disruption of Nrf2 S ignaling I mpairs F ormation of C apillary-L ike S tructures by CAECs
When seeded onto Matrigel matrices, control cells formed elaborated capillary networks in the presence of both VEGF and IGF-1 ( Figure 5A ). We found that siRNA knockdown of Nrf2 or overexpression of Keap1 significantly inhibited the formation of capillary-like structures by CAECs ( Figure 5A -C ) .
Disruption of Nrf2 S ignaling R enders CAECs S usceptible to O xidative S tress -I nduced A poptosis
An increased susceptibility to apoptotic cell death is thought to contribute to impaired angiogenesis and microvascular rarefaction in various pathophysiological conditions ( 21 ) and is considered an important mechanism of aging ( 29 , 30 , 33 -39 ) . To test whether siRNA knockdown of Nrf2 negatively affects cell survival, we treated CAECs with various pro-apoptotic stimuli. We found that knockdown of Nrf2 rendered CAECs signifi cantly more susceptible to the pro-apoptotic effects of H 2 O 2 , high glucose , or oxidized low-density lipoprotein as compared with the control group ( Figure 6 ).
D iscussion
The principal new fi nding of this study is that a functional Nrf2 pathway is essential for a healthy endothelial angiogenic response because all the major steps of the angiogenic process, including adhesion, proliferation, migration , and formation of capillary-like structures , are compromised by disruption of Nrf2 signaling in endothelial cells.
Increased production of reactive oxygen species (ROS) is known to activate Nrf2 via facilitating its dissociation from the inhibitory protein Keap1. The fi ndings showing that Nrf2 regulates angiogenesis are consistent with a central role of redox signaling pathways in multiple angiogenic processes in endothelial cells and the role of ROS in signal transduction by angiogenic growth factors (eg , VEGF, IGF-1, and angiopoetin-1 ; 40 -44 ). Accordingly, VEGF stimulation was shown to increase ROS production via activation of Rac-dependent NAD(P)H oxidase in endothelial cells ( 43 -48 ) , which mediates Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) autophosphorylation ( 47 ) . Recent studies demonstrate that NAD(P)H oxidase -dependent ROS production is involved in IGF-1 signaling as well ( 42 ) . It is logical to assume that local increases in ROS levels induced by activation of the VEGF and IGF-1 receptors activate Nrf2, which modulates the pro-angiogenic effects of VEGF and IGF-1. In addition, VEGF and IGF-1 may also directly activate Nrf2 in endothelial cells via phosphorylation mediated by the phosphatidylinositol 3-kinase -Akt pathway ( 8 , 49 ) . It is possible that Nrf2-driven induction of antioxidant enzymes has an important role in localizing ROS production and integration of specifi c redox signaling events, which are involved in angiogenesis. Indeed, recent studies demonstrate that Nrf2-driven pathways have an important role in angiogenic growth factor signaling by controlling the activity of the serine/threonine kinase domain of growth factor receptors ( 50 ) and, or, modulating the effects of HIF-1 α ( 51 ). This hypothesis is supported by the observations that genetic depletion of Nrf2 signifi cantly impairs the development of the secondary capillary network in the retina, which is known to form by angiogenesis in most species ( 52 ) . Moreover, a recent study reports that Nrf2 blockade suppresses colon tumor angiogenesis ( 53 ) . Further more , the Nrf2 targets, heme oxygenase-1 ( 54 , 55 ) , and thioredoxin ( 56 ) were shown to confer pro-angiogenic effects in animal disease models.
In addition to regulating angiogenic processes, Nrf2 also confers antiapoptotic effects, which are likely to have important roles in preserving the structural integrity of newly formed capillaries. Importantly, the present fi ndings and results of previous studies demonstrate that Nrf2 dysfunction signifi cantly impairs oxidative stress resistance in endothelial cells exacerbating apoptotic cell death under conditions associated with increased production of ROS ( 9 , 10 ) . These fi ndings also extend the results obtained in Nrf2 − / − murine embryonic fi broblasts showing decreased growth and downregulation of SIRT1 associated with a signifi cantly shorter cell survival ( 57 ) . There is good reason to believe that mitochondrial protective effects of Nrf2 activation (which likely prevent induction of the mitochondrial pathway of programmed cell death) signifi cantly contribute to its antiapoptotic effects ( 58 ) . In addition, there is also evidence that Nrf2 may modulate cellular sensitivity to apoptosis mediated via death receptor activation ( 59 ) .
The pathophysiological consequences of impaired angiogenesis and increased endothelial vulnerability to apoptosis associated with Nrf2 dysfunction are likely multiple. We posit that Nrf2 depletion may decrease capillary density in the heart and negatively affect cardiac angiogenesis and, or, collateral formation induced by physiological (eg , exercise) or pathological (eg , pressure overload) stimuli. Recent studies demonstrate that aging results in severe impairment of Nrf2 expression and activity in the vasculature ( 9 , 10 ), which is associated with an increased rate of endothelial apoptosis ( 10 , 27 , 60 ) and microvascular rarefaction ( 61 -63 ) . Laboratory studies also show that the ability of angiogenic cytokines to induce angiogenesis is signifi cantly blunted in aged endothelial cells ( 64 ) . Age-related Nrf2 dysfunction is associated with signifi cant increases in the production of ROS in endothelial cells ( 9 , 10 ) . Although ROS signaling is necessary for physiological angiogenesis ( 43 , 44 , 46 ) , there is evidence that increased oxidative stress has detrimental effects on endothelial angiogenic processes ( 65 ) .
We posit that microvascular rarefaction and impairment of compensatory proliferation of the coronary resistance vessels and the capillary network ( 61 ) associated with agerelated Nrf2 dysfunction may play a prominent role in the occurrence of cardiac dysfunction and failure with age. Importantly, although pro-angiogenic strategies work well in healthy, young laboratory animals, a number of large randomized placebo -controlled phase II/III clinical trials aimed at improving collateral circulation with angiogenic growth factors in patients with ischemic heart disease yielded disappointing results ( 66 -71 ) . It is thought that the negative results of the aforementioned clinical studies are due to the unresponsiveness of the vasculature to angiogenic stimulation in elderly patients ( 66 ) . In order to design more effective therapeutic approaches, it will be essential to determine whether pharmacological activation of Nrf2 renders aged endothelial cells responsive to angiogenic stimulation and, or, protects newly formed blood vessels from apoptosis. In that regard , it is signifi cant that in endothelial cells , Nrf2 can be activated pharmacologically by the polyphenol resveratrol ( 4 ) . Although resveratrol in supraphysiological concentrations (30 μ mol/L) was shown to inhibit angiogenic processes in cultured endothelial cells (likely by blocking cell proliferation and inhibiting endothelial α v β 3 integrin function, 72 , and, or, by causing dysregulation of microRNA signaling ; Ungvari, MD, PhD and Csiszar, MD, PhD, unpublished data , 2011 ), treatment with physiological doses of resveratrol in vivo was shown to promote angiogenesis in rodent models of myocardial infarction ( 73 ) . Resveratrol treatment was also shown to increase the number of capillaries in the brain of aged mice ( 74 ) and protect endothelial cells from apoptosis ( 25 , 75 , 76 ) , in addition to its documented diverse antiaging actions ( 75 , 77 -83 ) . Further studies are warranted to determine whether resveratrol and other activators of Nrf2 confer similar pro-angiogenic and endothelial protective effects in nonhuman primates and elderly patients as well. 
